{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["A2AAR/NF-\u03baB pathway", "Acute lung injury", "Apoptosis", "Inflammation", "Lipopolysaccharide", "Shufeng jiedu capsule"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36002086", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "21"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jep.2022.115661", "S0378-8741(22)00700-0"], "Journal": {"ISSN": "1872-7573", "JournalIssue": {"Volume": "298", "PubDate": {"Year": "2022", "Month": "Nov", "Day": "15"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-\u03baB to alleviate LPS-induced ALI.", "Pagination": {"StartPage": "115661", "MedlinePgn": "115661"}, "Abstract": {"AbstractText": ["Shufeng Jiedu capsule (SFJDC) is a pure form of traditional Chinese medicine (TCM) that contains eight medicinal plants. Known for its anti-inflammatory and antipyretic effects, it is mostly used to treat upper respiratory tract infections and other infectious diseases, such as colds, pharyngitis, laryngitis, and tonsillitis. Both acute lung injury (ALI) and COVID-19 are closely related to lung damage, primarily manifesting as lung inflammation and epithelial cell damage. However, whether SFJDC can improve ALI and by what mechanism remain unclear. The purpose of this study was to explore whether SFJDC could be used as a prophylactic treatment for COVID-19 by improving acute lung injury.", "The purpose of this study was to determine whether SFJDC could protect against ALI caused by lipopolysaccharide (LPS), and we wanted to determine how SFJDC reduces inflammation and apoptosis pharmacologically and molecularly.", "Preadministering SFJDC at 0.1\u00a0g/kg, 0.3\u00a0g/kg, or 0.5\u00a0g/kg for one week was followed by 5\u00a0mg/kg LPS to induce ALI in mice. Observations included the study of lung histomorphology, tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), and interleukin-6 (IL-6) secretion, as well as the ratio of lung wet/dry weights. In addition, RAW264.7\u00a0cells were treated for 24\u00a0h with 1\u00a0\u03bcg/mL LPS after being pretreated for 1\u00a0h with 0.5\u00a0mg/mL SFJDC. In the samples, we detected TNF-\u03b1, IL-1\u03b2, and IL-6. Cell apoptosis was detected by stimulating A549\u00a0cells for 24\u00a0h with RAW264.7 supernatant. Both in vitro and in vivo, the levels of A2A adenosine receptor (A2AAR), PKA, I\u03baB, p-I\u03baB, NF-\u03baB P65 (P65), p-NF-\u03baB P65 (p-P65), cleaved caspases-3 (Cc3), Bcl-2 associated X protein (Bax), and B-cell lymphoma-2 (Bcl-2) proteins were determined using Western blot analysis.", "Lung tissue morphology was improved as SFJDC decreased cytokine secretion, the ratio of lung wet/dry weights, and lung tissue secretion of proinflammatory cytokines. The expression of A2AAR was increased by SFJDC, and the phosphorylation of NF-\u03baB was inhibited. TUNEL staining and flow cytometry showed that SFJDC inhibited apoptosis by reducing the expression of Cc3 and the ratio of Bax/Bcl-2.", "According to the results of this study, SFJDC can reduce inflammation and inhibit apoptosis. A2AAR activation and regulation of NF-\u03baB expression are thought to make SFJDC anti-inflammatory and anti-apoptotic. A wide range of active ingredients may result in an anti-inflammatory and antipyretic effect with SFJDC."], "CopyrightInformation": "Copyright \u00a9 2022 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Liver Disease, Anhui Medical University, Hefei, Anhui, China; Center of Traditional Chinese Medicine Formula Granule, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Anti-inflammatory and Immunological Drugs, Ministry of Education, Hefei, China; Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China."}], "LastName": "Cai", "ForeName": "Junnan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Liver Disease, Anhui Medical University, Hefei, Anhui, China; Center of Traditional Chinese Medicine Formula Granule, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Anti-inflammatory and Immunological Drugs, Ministry of Education, Hefei, China; Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China."}], "LastName": "Wang", "ForeName": "Yu-Lian", "Initials": "YL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Liver Disease, Anhui Medical University, Hefei, Anhui, China; Center of Traditional Chinese Medicine Formula Granule, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Anti-inflammatory and Immunological Drugs, Ministry of Education, Hefei, China; Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China."}], "LastName": "Sheng", "ForeName": "Xiao-Dong", "Initials": "XD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Liver Disease, Anhui Medical University, Hefei, Anhui, China; Center of Traditional Chinese Medicine Formula Granule, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Anti-inflammatory and Immunological Drugs, Ministry of Education, Hefei, China; Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China."}], "LastName": "Zhang", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Liver Disease, Anhui Medical University, Hefei, Anhui, China; Center of Traditional Chinese Medicine Formula Granule, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Anti-inflammatory and Immunological Drugs, Ministry of Education, Hefei, China; Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China. Electronic address: lyuxw@ahmu.edu.cn."}], "LastName": "Lv", "ForeName": "Xiongwen", "Initials": "X"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Purinergic P1"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "bcl-2-Associated X Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "shufeng jiedu"}], "MeshHeadingList": [{"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Acute Lung Injury"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["pathology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-6"}, {"QualifierName": ["metabolism", "toxicity"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": [], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism", "therapeutic use"], "DescriptorName": "Receptors, Purinergic P1"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": ["metabolism"], "DescriptorName": "bcl-2-Associated X Protein"}], "CoiStatement": "Declaration of interest We certify that we have no business or personal ties to any improper organizations or individuals, and that we have no interest of any kind in any products, services or companies that could affect or comment on the manuscript."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Antonioli L., Blandizzi C., Pacher P., Hask\u00f3 G. Immunity, inflammation and cancer: a leading role for adenosine. Nat. Rev. Cancer. 2013;13:842\u2013857.", "ArticleIdList": ["24226193"]}, {"Citation": "Cai Y., Li H., Liu M., Pei Y., Zheng J., Zhou J., Luo X., Huang W., Ma L., Yang Q., Guo S., Xiao X., Li Q., Zeng T., Meng F., Francis H., Glaser S., Chen L., Huo Y., Alpini G., Wu C. Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity. Hepatology. 2018;68:48\u201361.", "ArticleIdList": ["PMC6033664", "29315766"]}, {"Citation": "Chambers E., Rounds S., Lu Q. Pulmonary endothelial cell apoptosis in emphysema and acute lung injury. Adv. Anat. Embryol. Cell Biol. 2018;228:63\u201386.", "ArticleIdList": ["PMC5930489", "29288386"]}, {"Citation": "Channappanavar R., Fehr A.R., Vijay R., Mack M., Zhao J., Meyerholz D.K., Perlman S. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 2016;19:181\u2013193.", "ArticleIdList": ["PMC4752723", "26867177"]}, {"Citation": "Channappanavar R., Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 2017;39:529\u2013539.", "ArticleIdList": ["PMC7079893", "28466096"]}, {"Citation": "D'Agnillo F., Walters K.A., Xiao Y., Sheng Z.M., Scherler K., Park J., Gygli S., Rosas L.A., Sadtler K., Kalish H., Blatti C.R., Zhu R., Gatzke L., Bushell C., Memoli M.J., O'Day S.J., Fischer T.D., Hammond T.C., Lee R.C., Cash J.C., Powers M.E., O'Keefe G.E., Butnor K.J., Rapkiewicz A.V., Travis W.D., Layne S.P., Kash J.C., Taubenberger J.K. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci. Transl. Med. 2021;13:j7790.", "ArticleIdList": ["PMC11000440", "34648357"]}, {"Citation": "Eckle T., Koeppen M., Eltzschig H.K. Role of extracellular adenosine in acute lung injury. Physiology. 2009;24:298\u2013306.", "ArticleIdList": ["19815856"]}, {"Citation": "Fan E., Fan J. Regulation of alveolar macrophage death in acute lung inflammation. Respir. Res. 2018;19:50.", "ArticleIdList": ["PMC5872399", "29587748"]}, {"Citation": "Gazoni L.M., Laubach V.E., Mulloy D.P., Bellizzi A., Unger E.B., Linden J., Ellman P.I., Lisle T.C., Kron I.L. Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J. Thorac. Cardiovasc. Surg. 2008;135:156\u2013165.", "ArticleIdList": ["18179933"]}, {"Citation": "Gessi S., Merighi S., Varani K., Borea P.A. Adenosine receptors in health and disease. Adv. Pharmacol. 2011;61:41\u201375.", "ArticleIdList": ["21586355"]}, {"Citation": "Gonzales J.N., Gorshkov B., Varn M.N., Zemskova M.A., Zemskov E.A., Sridhar S., Lucas R., Verin A.D. Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2014;306:L497\u2013L507.", "ArticleIdList": ["PMC3949083", "24414256"]}, {"Citation": "Gouda M.M., Bhandary Y.P. Acute lung injury: IL-17A-Mediated inflammatory pathway and its regulation by curcumin. Inflammation. 2019;42:1160\u20131169.", "ArticleIdList": ["31011925"]}, {"Citation": "Gustine J.N., Jones D. Immunopathology of hyperinflammation in COVID-19. Am. J. Pathol. 2021;191:4\u201317.", "ArticleIdList": ["PMC7484812", "32919977"]}, {"Citation": "Habashi N.M., Camporota L., Gatto L.A., Nieman G. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications. J. Appl. Physiol. 2021;130:877\u2013891. 1985.", "ArticleIdList": ["PMC7984238", "33444117"]}, {"Citation": "Hask\u00f3 G., Linden J., Cronstein B., Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 2008;7:759\u2013770.", "ArticleIdList": ["PMC2568887", "18758473"]}, {"Citation": "He M., Shi W., Yu M., Li X., Xu J., Zhu J., Jin L., Xie W., Kong H. Nicorandil attenuates LPS-induced acute lung injury by pulmonary endothelial cell protection via NF-\u03baB and MAPK pathways. Oxid. Med. Cell. Longev. 2019 2019.", "ArticleIdList": ["PMC6431468", "30984337"]}, {"Citation": "He X., Hu J.L., Li J., Zhao L., Zhang Y., Zeng Y.J., Dai S.S., He F.T. A feedback loop in PPAR\u03b3-adenosine A2A receptor signaling inhibits inflammation and attenuates lung damages in a mouse model of LPS-induced acute lung injury. Cell. Signal. 2013;25:1913\u20131923.", "ArticleIdList": ["23712033"]}, {"Citation": "He Y.Q., Zhou C.C., Yu L.Y., Wang L., Deng J.L., Tao Y.L., Zhang F., Chen W.S. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms. Pharmacol. Res. 2021;163", "ArticleIdList": ["PMC7522693", "33007416"]}, {"Citation": "Hendrickson C.M., Matthay M.A. Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS. Pulm. Circ. 2018;8", "ArticleIdList": ["PMC5912282", "29575977"]}, {"Citation": "Hoegl S., Brodsky K.S., Blackburn M.R., Karmouty-Quintana H., Zwissler B., Eltzschig H.K. Alveolar epithelial A2B adenosine receptors in pulmonary protection during acute lung injury. J. Immunol. 2015;195:1815\u20131824.", "ArticleIdList": ["PMC4530072", "26188061"]}, {"Citation": "Ju M., Liu B., He H., Gu Z., Liu Y., Su Y., Zhu D., Cang J., Luo Z. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting in\ufb02ammation and apoptosis through modulating TLR4/MyD88/NF-\u03baB pathway. Cell Cycle. 2018;17:2001\u20132018.", "ArticleIdList": ["PMC6260216", "30231673"]}, {"Citation": "Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front. Immunol. 2020;11:1722.", "ArticleIdList": ["PMC7417316", "32849610"]}, {"Citation": "Lee H., Abston E., Zhang D., Rai A., Jin Y. Extracellular vesicle: an emerging mediator of intercellular crosstalk in lung inflammation and injury. Front. Immunol. 2018;9:924.", "ArticleIdList": ["PMC5946167", "29780385"]}, {"Citation": "Leitch A.E., Duffin R., Haslett C., Rossi A.G. Relevance of granulocyte apoptosis to resolution of inflammation at the respiratory mucosa. Mucosal Immunol. 2008;1:350\u2013363.", "ArticleIdList": ["PMC7102379", "19079199"]}, {"Citation": "Li J., Chen Q., He X., Alam A., Ning J., Yi B., Lu K., Gu J. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through \u03b1(2)AR/PI3K/Akt pathway. J. Transl. Med. 2018;16:78.", "ArticleIdList": ["PMC5865375", "29566706"]}, {"Citation": "Li T., Wu Y.N., Wang H., Ma J.Y., Zhai S.S., Duan J. Dapk1 improves inflammation, oxidative stress and autophagy in LPS-induced acute lung injury via p38MAPK/NF-\u03baB signaling pathway. Mol. Immunol. 2020;120:13\u201322.", "ArticleIdList": ["32045770"]}, {"Citation": "Li X., Jamal M., Guo P., Jin Z., Zheng F., Song X., Zhan J., Wu H. Irisin alleviates pulmonary epithelial barrier dysfunction in sepsis-induced acute lung injury via activation of AMPK/SIRT1 pathways. Biomed. Pharmacother. 2019;118", "ArticleIdList": ["31545277"]}, {"Citation": "Liao Q., Chen W., Tong Z., Xue M., Gu T., Yuan Y., Song Z., Tao Z. Shufeng Jiedu capsules protect rats against LPS-induced acute lung injury via activating NRF2-associated antioxidant pathway. Histol. Histopathol. 2021;36:317\u2013324.", "ArticleIdList": ["33346364"]}, {"Citation": "Lindsay J., Esposti M.D., Gilmore A.P. Bcl-2 proteins and mitochondria--specificity in membrane targeting for death. Biochim. Biophys. Acta. 2011;1813:532\u2013539.", "ArticleIdList": ["21056595"]}, {"Citation": "Link A.A., Kino T., Worth J.A., McGuire J.L., Crane M.L., Chrousos G.P., Wilder R.L., Elenkov I.J. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J. Immunol. 2000;164:436\u2013442.", "ArticleIdList": ["10605040"]}, {"Citation": "Liu Y., Xiang D., Zhang H., Yao H., Wang Y. Hypoxia-inducible factor-1: a potential target to treat acute lung injury. Oxid. Med. Cell. Longev. 2020 2020.", "ArticleIdList": ["PMC7685819", "33282113"]}, {"Citation": "Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV) Biosci Trends. 2020;14:69\u201371.", "ArticleIdList": ["31996494"]}, {"Citation": "Majumdar S., Aggarwal B.B. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene. 2003;22:1206\u20131218.", "ArticleIdList": ["12606947"]}, {"Citation": "Martin T.R. Lung injury and repair in coronavirus disease 2019-related acute lung injury. Am. J. Pathol. 2022;192:406\u2013409.", "ArticleIdList": ["PMC8747841", "35026140"]}, {"Citation": "Mokra D., Kosutova P. Biomarkers in acute lung injury. Respir. Physiol. Neurobiol. 2015;209:52\u201358.", "ArticleIdList": ["25466727"]}, {"Citation": "Mowery N.T., Terzian W.T.H., Nelson A.C. Acute lung injury. Curr. Probl. Surg. 2020;57", "ArticleIdList": ["32505224"]}, {"Citation": "Nathan C. Points of control in inflammation. Nature. 2002;420:846\u2013852.", "ArticleIdList": ["12490957"]}, {"Citation": "Ohta A., Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001;414:916\u2013920.", "ArticleIdList": ["11780065"]}, {"Citation": "Qian J., Chen X., Shu S., Zhang W., Fang B., Chen X., Zhao Y., Liu Z., Liang G. Design and synthesis novel di-carbonyl analogs of curcumin (DACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI) Eur. J. Med. Chem. 2019;167:414\u2013425.", "ArticleIdList": ["30780088"]}, {"Citation": "Ragab D., Salah E.H., Taeimah M., Khattab R., Salem R. The COVID-19 cytokine storm; what we know so far. Front. Immunol. 2020;11:1446.", "ArticleIdList": ["PMC7308649", "32612617"]}, {"Citation": "Reutershan J., Cagnina R.E., Chang D., Linden J., Ley K. Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J. Immunol. 2007;179:1254\u20131263.", "ArticleIdList": ["17617618"]}, {"Citation": "Sands W.A., Martin A.F., Strong E.W., Palmer T.M. Specific inhibition of nuclear factor-kappaB-dependent inflammatory responses by cell type-specific mechanisms upon A2A adenosine receptor gene transfer. Mol. Pharmacol. 2004;66:1147\u20131159.", "ArticleIdList": ["15286208"]}, {"Citation": "Shaikh G., Cronstein B. Signaling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis. Purinergic Signal. 2016;12:191\u2013197.", "ArticleIdList": ["PMC4854836", "26847815"]}, {"Citation": "Sharma A.K., Linden J., Kron I.L., Laubach V.E. Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation. Respir. Res. 2009;10:58.", "ArticleIdList": ["PMC2711962", "19558673"]}, {"Citation": "Soy M., Keser G., Atag\u00fcnd\u00fcz P., Tabak F., Atag\u00fcnd\u00fcz I., Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin. Rheumatol. 2020;39:2085\u20132094.", "ArticleIdList": ["PMC7260446", "32474885"]}, {"Citation": "Sullivan G.W., Rieger J.M., Scheld W.M., Macdonald T.L., Linden J. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br. J. Pharmacol. 2001;132:1017\u20131026.", "ArticleIdList": ["PMC1572638", "11226132"]}, {"Citation": "Sun X., Cheng H., Liu B., Du Y., Dong J., Huang J. Icariin reduces LPS-induced acute lung injury in mice undergoing bilateral adrenalectomy by regulating GR\u03b1. Eur. J. Pharmacol. 2020;876", "ArticleIdList": ["32147435"]}, {"Citation": "Swenson K.E., Swenson E.R. Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury. Crit. Care Clin. 2021;37:749\u2013776.", "ArticleIdList": ["PMC8162817", "34548132"]}, {"Citation": "Tao Z., Gao J., Zhang G., Xue M., Yang W., Tong C., Yuan Y. Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK/NF-\u03baB pathway. Biosci Trends. 2014;8:45\u201351.", "ArticleIdList": ["24647112"]}, {"Citation": "Vel\u00e1zquez-Miranda E., D\u00edaz-Mu\u00f1oz M., V\u00e1zquez-Cuevas F.G. Purinergic signaling in hepatic disease. Purinergic Signal. 2019;15:477\u2013489.", "ArticleIdList": ["PMC6923300", "31576486"]}, {"Citation": "Wan L., Meng D., Wang H., Wan S., Jiang S., Huang S., Wei L., Yu P. Preventive and therapeutic effects of thymol in a lipopolysaccharide-induced acute lung injury mice model. Inflammation. 2018;41:183\u2013192.", "ArticleIdList": ["29019091"]}, {"Citation": "Wang J., Jiang M., Chen X., Montaner L.J. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 2020;108:17\u201341.", "ArticleIdList": ["PMC7323250", "32534467"]}, {"Citation": "Wang J., Cai X., Ma R., Lei D., Pan X., Wang F. Anti-inflammatory effects of sweroside on LPS-induced ALI in mice via activating SIRT1. Inflammation. 2021;44:1961\u20131968.", "ArticleIdList": ["33913051"]}, {"Citation": "Xia L., Shi Y., Su J., Friedemann T., Tao Z., Lu Y., Ling Y., Lv Y., Zhao R., Geng Z., Cui X., Lu H., Schr\u00f6der S. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study. Phytomedicine. 2021;85", "ArticleIdList": ["PMC7581328", "33158717"]}, {"Citation": "Xie W., Lu Q., Wang K., Lu J., Gu X., Zhu D., Liu F., Guo Z. miR-34b-5p inhibition attenuates lung inflammation and apoptosis in an LPS-induced acute lung injury mouse model by targeting progranulin. J. Cell. Physiol. 2018;233:6615\u20136631.", "ArticleIdList": ["PMC6001482", "29150939"]}, {"Citation": "Xu Y., Yang L., Wang L., Chen F. Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): a review. Drug Discov Ther. 2022;15:289\u2013299.", "ArticleIdList": ["34980761"]}, {"Citation": "Ye Q., Wang B., Mao J. The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19. J. Infect. 2020;80:607\u2013613.", "ArticleIdList": ["PMC7194613", "32283152"]}, {"Citation": "Zarrilli G., Angerilli V., Businello G., Sbaraglia M., Traverso G., Fortarezza F., Rizzo S., De Gaspari M., Basso C., Calabrese F., Dei T.A., Fassan M. The immunopathological and histological landscape of COVID-19-mediated lung injury. Int. J. Mol. Sci. 2021;22", "ArticleIdList": ["PMC7835817", "33478107"]}, {"Citation": "Zarrilli G., Angerilli V., Businello G., Sbaraglia M., Traverso G., Fortarezza F., Rizzo S., De Gaspari M., Basso C., Calabrese F., Dei T.A., Fassan M. The immunopathological and histological landscape of COVID-19-mediated lung injury. Int. J. Mol. Sci. 2021;22", "ArticleIdList": ["PMC7835817", "33478107"]}, {"Citation": "Zhang H., Lang W., Wang S., Li B., Li G., Shi Q. Echinacea polysaccharide alleviates LPS-induced lung injury via inhibiting inflammation, apoptosis and activation of the TLR4/NF-\u03baB signal pathway. Int. Immunopharm. 2020;88", "ArticleIdList": ["33182056"]}, {"Citation": "Zhao H., Liu Z., Shen H., Jin S., Zhang S. Glycyrrhizic acid pretreatment prevents sepsis-induced acute kidney injury via suppressing inflammation, apoptosis and oxidative stress. Eur. J. Pharmacol. 2016;781:92\u201399.", "ArticleIdList": ["27063444"]}, {"Citation": "Zhao J., Zhang G., Cui W., Tian B. [Progress of neutrophil extracellular traps in airway inflammation of acute lung injury/acute respiratory distress syndrome: review] Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020;36:664\u2013670.", "ArticleIdList": ["32727651"]}, {"Citation": "Zhao N., Xia G., Cai J., Li Z., Lv X.W. Adenosine receptor A2B mediates alcoholic hepatitis by regulating cAMP levels and the NF-KB pathway. Toxicol. Lett. 2022;359:84\u201395.", "ArticleIdList": ["35143882"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "2"}, {"Year": "2022", "Month": "7", "Day": "31"}, {"Year": "2022", "Month": "8", "Day": "17"}, {"Year": "2022", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "24", "Hour": "19", "Minute": "24"}, {"Year": "2022", "Month": "8", "Day": "21"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36002086", "PMC9392900", "10.1016/j.jep.2022.115661", "S0378-8741(22)00700-0"]}}], "PubmedBookArticle": []}